IFN-alpha/beta R2 Antibody (493715) [CoraFluor™ 1]
Novus Biologicals, part of Bio-Techne | Catalog # FAB4015CL1

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Neutralization
Label
CoraFluor 1
Antibody Source
Monoclonal Mouse IgG2B Clone # 493715
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line, NS0-derived recombinant human IFN‑ alpha/ beta R2
Ile27-Lys243
Accession # P48551
Ile27-Lys243
Accession # P48551
Specificity
Detects human IFN‑ alpha/ beta R2 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for IFN-alpha/beta R2 Antibody (493715) [CoraFluor™ 1]
Application
Recommended Usage
Neutralization
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark. Do not freeze.
Background: IFN-alpha/beta R2
Long Name
Interferon alpha/beta Receptor 2
Alternate Names
IFN-aR2, IFN-bR2, IFNAR2, IFNbR2
Additional IFN-alpha/beta R2 Products
Product Documents for IFN-alpha/beta R2 Antibody (493715) [CoraFluor™ 1]
Product Specific Notices for IFN-alpha/beta R2 Antibody (493715) [CoraFluor™ 1]
CoraFluor (TM) is a trademark of Bio-Techne Corp. Sold for research purposes only under agreement from Massachusetts General Hospital. US patent 2022/0025254
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...